Jeff O’Donnell, Sr. has extensive experience in the Healthcare industry, merging a solid, traditional corporate background with emerging growth experience. Jeff brings more than 20 years of Board and Chief Executive experience running emerging medical device firms. Businesses under his direct leadership have achieved over $1.5 Billion in value creation from initial public offering of stock or mergers and acquisitions. Currently, Jeff is the President and CEO of Trice Medical. Trice is an emerging growth medical device company developing optical needles used by orthopedic surgeons to diagnose soft tissue damage of joints. In 2008, Jeff started and ran Embrella Cardiovascular, a medical device startup company, which was sold in 2011 to Edwards Lifesciences (NYSE: EW). Prior to Embrella Cardiovascular, Jeff served as President and CEO of PhotoMedex (NASDAQ: PHMD) from 1999 to 2009. Prior to PhotoMedex, Jeff was the President and CEO of Cardiovascular Dynamics. His team took CCVD public on NASDAQ in June of 1996 and purchased Radiance Medical Systems and Endologix (NASDAQ: ELGX). From 1994 to 1995 Jeff held the position of President and CEO of Kensey Nash Corporation (NASDAQ: KNSY). Additionally, he has held several senior sales and marketing management positions at Boston Scientific Corporation, Guidant Corporation and with Johnson & Johnson’s Orthopedic Division. In 2005, Jeff was named LifeSciences CEO of the Year by Price Waterhouse Coopers. In 2011, Jeff was named the Greater Philadelphia Emerging Entrepreneur Of The Year by Ernst & Young. Jeff is a previous director for Cardiac Science (7 yrs.) and Endologix (12 yrs.) and is currently on the Board of BioSig Technologies; he also serves as Chairman of the Board of Strata Skin Sciences (NASDAQ: SSKN). Jeff is a graduate of LaSalle University in Philadelphia earning a B.S. in Business Administration
Chief Financial Officer
Craig Carra has spent the majority of his twenty year career holding various executive level positions with emerging growth, medical device and service companies. Craig’s career started as an auditor with Coopers & Lybrand (PricewaterhouseCoopers). From 1996-2002, Craig served as Corporate Controller and Treasurer for Surgical Laser Technologies (SLT), a medical device company where he lead operational efficiencies with strict cash flow management to restore this turn-around Company and enabled it to grow through acquisition. From 2002-2012, Craig served as VP Sales and Business Development for PhotoMedex (NASDAQ: PHMD). Combining his financial and operational background with his strategic thinking and leadership ability, Craig built a strong U.S. sales team and developed new business models to significantly increase both annual recurring revenue and capital equipment sales. Prior to Trice, Craig served as the CFO and also led Business Development for Ella Health, a venture backed, healthcare services company. At Ella Health, he was responsible for securing new equity and debt financing to support the growth of the business and was successful in establishing strategic partnerships with physicians to open several new health centers. Craig holds an Executive MBA Degree from Villanova University and is a CPA.
Mr. Foster is an experienced Sales and Marketing professional with twenty years of progressively increasing responsibility in the medical device industry. Mark brings a unique combination of sales, marketing, organizational, operational and strategic planning skills to Trice Medical. He spent the last eight years building Smith & Nephew’s U.S. Sports Medicine Division to the powerhouse that it is today. In his last role there, he was responsible for all U.S. Commercial Operations (roughly $600M.) Mr. Foster also worked on M&A activities and served as the U.S. Commercial Integration Lead for Smith and Nephew’s largest acquisition, Arthrocare. Prior to Smith & Nephew, Mark served as the Director, Sales Operation & Training, for Boston Scientific’s Neurovascular Division, promoted to this position after spending five years growing and developing its GI Endoscopy Division. Mark is a graduate of the University of Richmond where he earned his B.A.
Richard H. Washburn
Chief Operating Officer
Rick Washburn has twenty years of experience in new product development and medical device commercialization. Prior to Trice, Rick served in a variety of sales and marketing roles with orthopedic companies. The majority of his time was with Globus Medical where his roles and responsibilities paralleled the growth of the company from 20 to over 500 employees; he was a Senior Director when he left Globus to preside over Core Essence Orthopaedics. As CE’s President, Rick developed a strategic refocusing for the struggling maker of orthopedic extremity products, stabilized the company and successfully sold its assets for CE’s investors. Additionally, he worked in orthobiologics product maketing at Interpore Cross for three years and spent over 8 years in product development designing products for Apple, Microsoft and Nike. Rick received his B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute, Troy, NY and his MBA from UCLA’s Anderson School of Management, Los Angeles, CA.